Thame, United Kingdom · Founded 2022 · Privately Held (backing)
Developer of a PCR testing platform designed to make precision diagnostics accessible to all. Signatur Biosciences is based in Thame, United Kingdom and was founded in 2022. Its last reported valuation was $7.1 million in Jan 2022. It has raised $7.5 million.
Last reported valuation
$7.1M
Oct 2026
Priced at
—
Total raised
$7.5M
Last round
—
Team — not yet on record
No current team members for Signatur Biosciences are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of Signatur Biosciences with a free Private Market View account
·Watch Signatur Biosciences: the Monday email on marks, rounds and moves
